Key Insights

Highlights

Success Rate

50% trial completion

Treatment Research

3 treatments under study, led by Standard Local Care Dressing

Research Leaders

7 sponsors active, led by Susan P. Perrine

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

50.0%

1 terminated out of 2 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed with results

Key Signals

1 with results50% success

Data Visualizations

Phase Distribution

2Total
Phase 2 (2)

Trial Status

Terminated1
Completed1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT00004412Phase 2CompletedPrimary

Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers

NCT00790608Phase 2TerminatedPrimary

Clinical Trial on the Reduction of Methicillin Resistant Staphylococcus Aureus (MRSA)

Showing all 2 trials

Research Network

Common Treatments

  • Standard Local Care Dressing1
  • Arginine Butyrate1
  • Nitric Oxide1

Active Sponsors

  • Susan P. Perrine1
  • University of Illinois at Chicago1
  • Icahn School of Medicine at Mount Sinai1
  • Boston Medical Center1
  • University of Tennessee1

Top Investigators

Related Conditions

  • Methicillinresistant Staphylococcus Aureus Infection1
  • Sickle Cell Anemia1

Activity Timeline